In-depth guides
Plain-language guides explain the questions people often raise about ibogaine treatment for methadone dependence. For a broader orientation to the topic and its limits, begin with Lanternwick’s main ibogaine and methadone overview.
Independent information resource
Services
Lanternwick organizes guides, comparisons, research summaries, and practical questions for people considering ibogaine after methadone. The focus is context: what is known, what remains uncertain, and why safety and established care matter.
What we provide
Information for decisions that deserve more than a simple claim.
These are informational offerings, not clinical services. They are designed to help readers slow down, identify important questions, and keep evidence limits and serious risks visible.
Decision frameworks
Our frameworks help separate a treatment claim from the information needed to assess it: evidence quality, medication history, screening questions, withdrawal concerns, follow-up, and emergency planning. They do not recommend an individual course of care.
Comparisons and glossary context
Comparisons put ibogaine claims beside established approaches for opioid use disorder and clarify common terms. Methadone is a medication used in treatment for opioid use disorder, a topic summarized by the Substance Abuse and Mental Health Services Administration’s treatment guidance.
Research summaries and FAQs
Research summaries distinguish preliminary findings from proof, while FAQs collect recurring practical questions in one place. Our approach and editorial principles explain why uncertainty is stated directly rather than filled with reassurance.
Evidence, in context
A research summary is not a treatment recommendation.
Ibogaine is a psychoactive substance associated with the iboga plant, but a definition alone does not establish safety or effectiveness. The background history of ibogaine can help orient readers, while treatment decisions require more careful attention to the evidence and to individual medical circumstances.
Lanternwick’s summaries focus on what a study can and cannot show, including design limits, size, follow-up, and the difference between reported experience and demonstrated clinical benefit. This is especially important where methadone changes, withdrawal, and other health factors may be involved.
A steadier way to use this information
These resources are built for people considering ibogaine after methadone, their supporters, and anyone trying to assess a difficult subject without being pushed toward a conclusion.
- Use guides to identify questions that should not be skipped.
- Compare claims with established care instead of treating alternatives as interchangeable.
- Bring individual medical and medication questions to qualified professionals.
Common questions
Clear scope, clear limits.
Does Lanternwick provide treatment or medical advice?
No. Lanternwick is an independent information resource, not a clinic, medical provider, or licensed treatment center. Its material is not medical or legal advice and does not replace individualized care from qualified professionals.
Why keep established treatment options in view?
Opioid use disorder is a health condition for which evidence-based treatment exists. The CDC’s overview of treatment for opioid use disorder describes medication treatment and other supports; that context matters when reviewing claims about ibogaine after methadone.
Where do outside perspectives fit?
Independent context can help readers recognize how different communities discuss the subject. For another perspective on ibogaine-related conversation, Ibogaine Basketball’s discussion space is available alongside, not in place of, careful evidence and safety review.
Start with context
Information that makes room for uncertainty.
Lanternwick helps readers examine ibogaine and methadone dependence without presenting ibogaine as a proven replacement for methadone care. Safety questions and evidence limits belong at the center of the conversation.
Explore safety and risks